Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Afatinib Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Afatinib Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Afatinib Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 30mg Tables
    • 1.4.3 40mg Tables
    • 1.4.4 50mg Tables
    • 1.4.5 25mg Tables
    • 1.4.6 20mg Tables
    • 1.4.7 Other
  • 1.5 Market by Application
    • 1.5.1 Global Afatinib Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital
    • 1.5.3 Clinic
    • 1.5.4 Drug Center
    • 1.5.5 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Afatinib Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Afatinib Industry
      • 1.6.1.1 Afatinib Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Afatinib Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Afatinib Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Afatinib Market Perspective (2015-2026)
  • 2.2 Afatinib Growth Trends by Regions
    • 2.2.1 Afatinib Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Afatinib Historic Market Share by Regions (2015-2020)
    • 2.2.3 Afatinib Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Afatinib Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Afatinib Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Afatinib Players by Market Size
    • 3.1.1 Global Top Afatinib Players by Revenue (2015-2020)
    • 3.1.2 Global Afatinib Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Afatinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Afatinib Market Concentration Ratio
    • 3.2.1 Global Afatinib Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Afatinib Revenue in 2019
  • 3.3 Afatinib Key Players Head office and Area Served
  • 3.4 Key Players Afatinib Product Solution and Service
  • 3.5 Date of Enter into Afatinib Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Afatinib Historic Market Size by Type (2015-2020)
  • 4.2 Global Afatinib Forecasted Market Size by Type (2021-2026)

5 Afatinib Breakdown Data by Application (2015-2026)

  • 5.1 Global Afatinib Market Size by Application (2015-2020)
  • 5.2 Global Afatinib Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Afatinib Market Size (2015-2020)
  • 6.2 Afatinib Key Players in North America (2019-2020)
  • 6.3 North America Afatinib Market Size by Type (2015-2020)
  • 6.4 North America Afatinib Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Afatinib Market Size (2015-2020)
  • 7.2 Afatinib Key Players in Europe (2019-2020)
  • 7.3 Europe Afatinib Market Size by Type (2015-2020)
  • 7.4 Europe Afatinib Market Size by Application (2015-2020)

8 China

  • 8.1 China Afatinib Market Size (2015-2020)
  • 8.2 Afatinib Key Players in China (2019-2020)
  • 8.3 China Afatinib Market Size by Type (2015-2020)
  • 8.4 China Afatinib Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Afatinib Market Size (2015-2020)
  • 9.2 Afatinib Key Players in Japan (2019-2020)
  • 9.3 Japan Afatinib Market Size by Type (2015-2020)
  • 9.4 Japan Afatinib Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Afatinib Market Size (2015-2020)
  • 10.2 Afatinib Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Afatinib Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Afatinib Market Size by Application (2015-2020)

11 India

  • 11.1 India Afatinib Market Size (2015-2020)
  • 11.2 Afatinib Key Players in India (2019-2020)
  • 11.3 India Afatinib Market Size by Type (2015-2020)
  • 11.4 India Afatinib Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Afatinib Market Size (2015-2020)
  • 12.2 Afatinib Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Afatinib Market Size by Type (2015-2020)
  • 12.4 Central & South America Afatinib Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Boehringer Ingelheim
    • 13.1.1 Boehringer Ingelheim Company Details
    • 13.1.2 Boehringer Ingelheim Business Overview and Its Total Revenue
    • 13.1.3 Boehringer Ingelheim Afatinib Introduction
    • 13.1.4 Boehringer Ingelheim Revenue in Afatinib Business (2015-2020))
    • 13.1.5 Boehringer Ingelheim Recent Development
  • 13.2 Hengrui Medicine
    • 13.2.1 Hengrui Medicine Company Details
    • 13.2.2 Hengrui Medicine Business Overview and Its Total Revenue
    • 13.2.3 Hengrui Medicine Afatinib Introduction
    • 13.2.4 Hengrui Medicine Revenue in Afatinib Business (2015-2020)
    • 13.2.5 Hengrui Medicine Recent Development
  • 13.3 Beacon Pharma
    • 13.3.1 Beacon Pharma Company Details
    • 13.3.2 Beacon Pharma Business Overview and Its Total Revenue
    • 13.3.3 Beacon Pharma Afatinib Introduction
    • 13.3.4 Beacon Pharma Revenue in Afatinib Business (2015-2020)
    • 13.3.5 Beacon Pharma Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Afatinib status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Afatinib development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Boehringer Ingelheim
    Hengrui Medicine
    Beacon Pharma
    ...

    Market segment by Type, the product can be split into
    30mg Tables
    40mg Tables
    50mg Tables
    25mg Tables
    20mg Tables
    Other
    Market segment by Application, split into
    Hospital
    Clinic
    Drug Center
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Afatinib status, future forecast, growth opportunity, key market and key players.
    To present the Afatinib development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Afatinib are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now